Specifically, the suppression of PDE4D activity leads to increased intracellular cAMP levels, resulting in reduced oncogenic properties such as colony formation and cell proliferation in DLD-1 CRC cells [94] (Table 1). The gene discussed is PDE4D; the disease is colorectal carcinoma.